alway
want
save
world
scourg
viru
infect
develop
better
drug
vaccin
fulli
understand
intricaci
virushost
interact
first
step
achiev
goal
requir
abil
view
process
grand
scale
advent
highthroughput
technolog
dna
microarray
mass
spectrometri
provid
first
opportun
obtain
view
describ
effort
use
tool
focu
chang
cellular
gene
express
protein
abund
occur
respons
viru
infect
examin
chang
comprehens
manner
abl
discov
excit
new
insight
innat
immun
interferon
cytokin
signal
strategi
use
virus
overcom
cellular
defens
function
genom
may
yet
save
world
killer
virus
time
receiv
milstein
award
septemb
laboratori
embark
excit
new
ventur
becom
fascin
novel
opportun
becom
avail
sequenc
human
genom
advent
highthroughput
technolog
dna
microarray
mass
spectrometri
technolog
provid
way
obtain
nearli
comprehens
view
biolog
system
convinc
offer
best
chanc
learn
everyth
know
complex
interplay
virus
cell
infect
past
eight
year
laboratori
work
tirelessli
even
obsess
incorpor
genom
proteom
inform
technolog
research
although
certainli
nt
yet
know
everyth
know
virushost
interact
made
tremend
progress
remain
convinc
genom
proteom
approach
fundament
forc
push
field
virolog
forward
year
come
articl
provid
sampl
use
technolog
discoveri
made
technolog
continu
evolv
initi
foray
world
genom
began
cdna
microarray
spot
inhous
use
commerci
avail
collect
cdna
clone
get
new
technolog
run
requir
month
work
seemingli
endless
frustrat
gari
geiss
final
abl
use
array
repres
human
gene
evalu
chang
cellular
gene
express
occur
tcell
line
infect
human
immunodefici
viru
type
straightforward
studi
analyz
two
time
point
infect
thrill
observ
tempor
regul
gene
involv
tcell
signal
subcellular
traffick
transcript
regul
despit
simplist
studi
appear
first
ever
appli
genom
aid
research
cover
articl
publish
virolog
technolog
place
eager
appli
broad
rang
experiment
system
possibl
seem
endless
inde
rapidli
began
array
cell
infect
varieti
differ
virus
expos
doublestrand
rna
dsrna
interferon
treatment
figur
next
studi
quantum
leap
sophist
microarray
contain
cdna
experiment
system
complex
time
profil
cellular
gene
express
chang
occur
hela
cell
infect
influenza
viru
analyz
two
time
point
infect
addit
evalu
cellular
respons
heatinactiv
viru
allow
us
identifi
gene
express
chang
independ
viral
replic
gene
involv
protein
synthesi
transcript
regul
cytokin
signal
induc
replic
viru
mani
chang
suggest
activ
cellular
antivir
respons
interestingli
viral
replic
also
result
downregul
mani
cellular
gene
particularli
later
time
point
gene
express
pattern
induc
inactiv
viru
includ
induct
cellular
metallothionein
gene
may
repres
protect
respons
virusinduc
oxid
stress
earli
use
microarray
also
includ
first
systemat
attempt
defin
full
repertoir
dsrnaregul
gene
use
array
conjunct
polysom
fraction
identifi
cellular
viral
mrna
increas
abund
select
recruit
polyribosom
follow
influenza
viru
infect
dsrna
studi
identifi
dsrnastimul
gene
encod
protein
involv
broad
rang
cellular
function
metabol
pathway
addit
studi
show
first
time
mani
gene
also
downregul
dsrna
polysom
fraction
studi
head
john
kash
reveal
mani
cellular
mrna
recruit
polyribosom
influenza
viru
infect
involv
control
cell
prolifer
surviv
mitogenesi
inflammatori
respons
addit
mani
mrna
contain
put
bind
site
cellular
mrnabind
protein
also
specif
interact
discret
conserv
region
viral
untransl
region
use
microarray
extend
increas
number
experiment
system
quickli
found
cope
avalanch
data
manag
huge
amount
inform
gener
multipl
array
experi
bioinformat
group
head
jeff
furlong
develop
custom
gene
express
databas
call
express
array
manag
addit
serv
central
data
repositori
express
array
manag
function
laboratori
inform
manag
system
provid
streamlin
data
analysi
pipelin
provid
mechan
publish
gene
express
data
scientif
commun
avail
http
expressionviromicswashingtonedu
core
genom
proteom
data
analysi
function
perform
use
rosetta
biosoftwar
system
resolv
elucid
system
design
manag
analyz
larg
amount
gene
express
mass
spectrometri
data
contain
suit
higherord
analysi
tool
explor
genom
proteom
data
greater
depth
also
use
varieti
tool
provid
divers
analyt
choic
exampl
use
spotfir
decisionsit
format
data
analysi
use
tool
ingenu
pathway
analysi
metacor
genego
tool
allow
us
leverag
proprietari
biolog
content
databas
examin
gene
express
protein
abund
data
context
complex
pathway
identifi
connect
differenti
express
gene
sean
proll
bryan
paeper
jon
rue
provid
laboratori
expert
guidanc
use
tool
ensur
data
move
effici
complex
pipelin
earlier
discov
hepat
c
viru
hcv
use
nonstructur
protein
repress
interferoninduc
protein
kinas
pkr
primari
mediat
antivir
effect
interferon
first
applic
gene
express
profil
hcv
research
therefor
evalu
effect
interferon
treatment
cellular
gene
express
determin
whether
abl
alter
pattern
express
gari
geiss
head
studi
examin
effect
interferon
treatment
use
sever
type
human
cell
includ
hela
cell
liver
cell
line
primari
fetal
hepatocyt
respons
interferon
approxim
gene
examin
consist
induc
cell
type
anoth
induc
cell
typespecif
manner
search
interferonstimul
respons
element
isr
genom
dna
locat
upstream
interferonstimul
gene
reveal
previous
identifi
novel
put
isr
express
partial
block
interferonmedi
induct
interferonstimul
gene
inhibit
induct
report
gene
driven
isrecontain
promot
suggest
may
play
role
hcv
resist
interferon
studi
also
set
stage
use
genom
better
understand
interferon
respons
vari
mechan
use
virus
evad
effect
interferon
realli
acceler
hcv
genom
program
award
nation
institut
drug
abus
nida
center
translat
clinic
relev
genom
studi
http
nidaviromicswashingtonedu
maria
smith
head
mani
earli
studi
first
look
novel
tumor
marker
surgic
liver
sampl
patient
hepatocellular
carcinoma
hcc
studi
use
microarray
contain
human
cdna
reveal
set
potenti
hcc
marker
gene
upregul
major
tumor
analyz
hcc
marker
set
contain
sever
cancerrel
gene
well
set
gene
encod
secret
plasma
protein
may
provid
potenti
serolog
marker
hcc
perform
similar
set
analys
surgic
materi
core
biopsi
specimen
obtain
hcvinfect
patient
liver
cirrhosi
importantli
studi
also
includ
analysi
normal
liver
sampl
determin
normal
physiolog
variat
gene
express
identifi
marker
associ
cirrhosi
gene
differenti
express
normal
liver
hcc
subtract
set
gene
differenti
express
cirrhot
liver
result
gene
set
includ
gene
express
activ
lymphocyt
infiltr
cirrhot
liver
gene
involv
remodel
extracellular
matrix
cellcel
interact
associ
cytoskeleton
rearrang
antiapoptot
pathway
signal
interferon
respons
togeth
analysi
identifi
sever
potenti
gene
express
marker
hcvassoci
liver
diseas
contribut
rapidli
expand
databas
experi
describ
hcv
pathogenesi
perhap
one
promis
applic
genom
hcvassoci
liver
diseas
work
serial
liver
biopsi
sampl
hcvinfect
liver
transplant
patient
liver
transplant
recipi
infect
hcv
develop
recurr
hepat
soon
transplant
case
progress
fibrosi
within
two
year
transplant
goal
identifi
molecular
process
influenc
liver
diseas
progress
find
potenti
gene
express
marker
earli
fibrosi
achiev
goal
work
close
clinician
liver
transplant
unit
univers
washington
includ
ann
larson
robert
carith
jame
perkin
collect
biopsi
sampl
integr
gene
express
data
obtain
sampl
clinic
observ
initi
analys
perform
serial
liver
biopsi
specimen
obtain
transplant
recipi
month
transplant
gene
express
data
compar
clinic
observ
gene
express
data
obtain
nontranspl
hcvinfect
uninfect
liver
sampl
analys
reveal
sever
specif
gene
express
pattern
first
uniqu
transplant
recipi
regardless
infect
statu
correspond
gene
encod
stress
respons
protein
blood
protein
involv
coagul
differenti
express
respons
posttransplant
graft
recoveri
second
pattern
specif
hcvinfect
sampl
includ
increas
express
gene
encod
compon
interferonmedi
antivir
respons
immun
system
pattern
absent
suppress
patient
develop
earli
fibrosi
indic
diseas
progress
might
result
impair
liver
respons
infect
final
identifi
gene
express
pattern
specif
biopsi
specimen
four
hcvinfect
patient
develop
earli
fibrosi
transplant
identifi
gene
express
pattern
may
prove
use
diagnost
prognost
applic
hcvinfect
patient
includ
predict
earli
progress
fibrosi
continu
collect
analyz
biopsi
sampl
new
patient
recruit
studi
enabl
us
obtain
increas
level
confid
predict
power
marker
identifi
recent
studi
kathi
walter
sharon
leder
examin
gene
express
profil
differenti
alcoholand
hcvinduc
liver
cirrhosi
gene
express
pattern
associ
hcvinduc
pathogenesi
individu
coinfect
found
global
gene
express
pattern
vari
significantli
depend
upon
etiolog
liver
diseas
stage
liver
cirrhosi
differenti
base
gene
express
pattern
ethanolinduc
hcvinduc
diseas
mani
gene
express
chang
specif
observ
hcvinfect
cirrhot
liver
associ
activ
innat
immun
respons
contrast
found
intrahepat
global
gene
express
profil
differ
hcvand
coinfect
individu
howev
specif
gene
express
pattern
may
associ
hcvinduc
pathogenesi
identifi
pattern
similar
gene
express
profil
transplant
patient
progress
fibrosi
within
one
year
transplant
suggest
may
also
relev
predict
diseas
progress
although
clinic
sampl
provid
consider
insight
chang
cellular
gene
express
occur
liver
diseas
progress
necessarili
ideal
studi
investig
molecular
mechan
respons
chang
type
studi
typic
requir
anim
model
experiment
manipul
regard
research
hcv
field
significantli
enhanc
develop
mous
model
hcv
infect
model
develop
lorn
tyrrel
norman
kneteman
univers
alberta
canada
base
sever
combin
immunodefici
disord
scid
beigealbumin
alb
urokinas
plasminogen
activ
upa
transgen
mous
intrasplen
inject
freshli
isol
human
hepatocyt
mice
lead
repopul
mous
liver
human
hepatocyt
result
mous
contain
chimer
mousehuman
liver
anim
persist
infect
varieti
hcv
genotyp
chimer
mous
model
provid
number
featur
make
use
system
studi
hcvhost
interact
group
mice
transplant
hepatocyt
differ
donor
opportun
analyz
hostspecif
respons
hcv
addit
lack
adapt
immun
respons
anim
make
possibl
distinguish
virusmedi
immunemedi
effect
gene
express
kathi
walter
use
model
character
host
transcript
respons
hcv
infect
liver
sampl
anim
typic
small
percentag
contamin
mous
liver
tissu
first
evalu
level
crosshybrid
mous
liver
mrna
human
probe
present
microarray
small
set
gene
identifi
less
gene
present
array
either
remov
subsequ
data
analysi
chang
express
gene
valid
use
humanspecif
quantit
realtim
pcr
initi
seri
experi
group
mice
transplant
hepatocyt
differ
donor
inocul
singl
sourc
hcv
gene
express
profil
perform
character
host
respons
infect
although
hcvinfect
anim
show
evid
interferon
respons
level
respons
intens
number
upregul
interferoninduc
gene
vari
anim
depend
upon
origin
donor
hepatocyt
result
indic
host
genet
factor
contribut
variat
host
respons
hcv
includ
activ
innat
antivir
signal
pathway
mice
weak
interferon
respons
also
tend
high
level
intrahepat
hcv
rna
indic
ineffect
interferon
respons
may
allow
increas
level
viral
replic
anim
also
accumul
higher
number
differenti
express
gene
mice
strong
interferon
respons
interestingli
also
observ
impair
interferon
respons
accumul
increas
number
differenti
express
gene
intrahepat
gene
express
profil
transplant
patient
develop
fibrosi
within
one
year
transplant
hcv
research
nida
center
also
provid
entri
point
proteom
abil
look
protein
content
cell
provid
strong
complement
genom
analys
allow
us
evalu
gene
express
chang
respons
viru
infect
translat
chang
abund
protein
molecul
directli
carri
biolog
function
moreov
proteom
analysi
bodi
fluid
blood
hold
promis
identifi
candid
biomark
human
diagnost
prognost
applic
initi
ventur
realm
proteom
led
wei
yan
collabor
ruedi
aebersold
institut
system
biolog
began
use
tandem
mass
spectrometri
analyz
global
proteom
hepatoma
cell
line
cultur
primari
immort
human
fetal
hepatocyt
also
use
isotop
code
affin
tag
icat
technolog
measur
chang
protein
abund
occur
human
hepatocyt
respons
interferon
treatment
analys
led
gener
liver
proteom
dataset
consist
uniqu
protein
among
identifi
protein
interferonregul
protein
play
role
multitud
cellular
function
includ
antivir
defens
immun
respons
cell
metabol
signal
transduct
data
also
contribut
develop
peptideatla
public
resourc
annot
valid
human
genom
map
identifi
peptid
sequenc
human
genom
sequenc
recent
proteom
work
team
richard
smith
battel
pacif
northwest
nation
laboratori
pnnl
first
studi
smith
group
use
high
mass
accuraci
fourier
transform
ion
cyclotron
reson
fticr
mass
spectrometri
coupl
accur
mass
time
amt
tag
approach
perform
global
proteom
analys
cell
contain
fulllength
hcv
replicon
use
sensit
technolog
identifi
protein
firstpass
mean
detect
chang
protein
abund
associ
hcv
infect
also
perform
semiquantit
comparison
total
peptid
identif
peptidespectr
count
peptidehit
approach
reveal
hcvrelat
perturb
abund
varieti
protein
associ
lipid
metabol
oxid
stress
also
taken
advantag
nanoproteom
platform
avail
pnnl
perform
proteom
studi
human
liver
biopsi
sampl
yield
limit
amount
protein
studi
perform
use
highsensit
fticr
mass
spectromet
coupl
amt
tag
approach
cell
protein
databas
use
method
identifi
protein
protein
digest
obtain
liver
biopsi
sampl
protein
identifi
includ
mani
relev
hcv
infect
liver
diseas
includ
cellular
protein
involv
lipid
metabol
interferon
respons
number
protein
identifi
approach
consider
larger
report
publish
studi
liver
proteom
lesssensit
method
requir
milligram
amount
protein
lysat
identifi
hundr
protein
deborah
diamond
lead
proteom
research
laboratori
recent
author
review
fulli
discuss
current
develop
applic
proteom
liver
diseas
research
influenza
research
mainstay
laboratori
year
mention
earlier
earliest
genom
studi
perform
cell
infect
influenza
viru
today
worldwid
attent
focus
highli
pathogen
avian
influenza
loom
threat
new
pandem
influenza
research
taken
renew
vigor
one
prioriti
research
develop
improv
anim
model
better
understand
influenza
pathogenesi
develop
new
diagnost
therapeut
vaccin
strategi
import
compon
prepared
next
influenza
pandem
past
two
year
taken
challeng
develop
macaqu
influenza
infect
model
featur
genom
proteom
analys
key
compon
experiment
design
carol
baskin
taken
lead
role
effort
first
report
use
genom
technolog
character
experiment
influenza
viru
infect
use
pigtail
macaqu
model
studi
perform
use
mildli
pathogen
strain
viru
goal
construct
blueprint
uncompl
influenza
infect
gene
express
profil
perform
lung
tissu
tracheobronchi
lymph
node
reveal
numer
gene
associ
interferon
respons
differenti
express
particularli
day
inocul
also
observ
increas
express
gene
encod
variou
mediat
chemotaxi
adhes
transmigr
immun
cell
suggest
traffick
cell
lung
tracheobronchi
lymph
node
confirm
histopatholog
addit
studi
reveal
gene
express
chang
relev
process
antigen
mhc
class
complex
particularli
lung
tissu
mani
gene
encod
protein
relev
tcell
function
induc
one
time
point
gene
express
profil
perform
studi
done
use
human
cdna
microarray
recent
option
avail
studi
use
nonhuman
primat
howev
extens
use
macaqu
model
wide
varieti
human
diseas
aid
research
particular
part
push
develop
genom
resourc
focus
macaqu
speci
effort
result
sequenc
rhesu
macaqu
genom
jame
wallac
head
effort
use
extens
sequenc
inform
develop
oligonucleotid
microarray
contain
uniqu
macaqu
sequenc
addit
inform
relat
nonhuman
primat
genom
also
avail
macaqueorg
web
site
develop
dissemin
macaqu
genom
proteom
data
resourc
macaqu
oligonucleotid
array
use
followup
studi
focus
earli
innat
immun
respons
macaqu
infect
influenza
viru
studi
led
tracey
baa
carol
baskin
also
perform
genom
analys
whole
blood
sampl
infect
anim
determin
whether
could
detect
gene
express
signatur
blood
would
correl
detect
lung
gener
genom
analys
lung
tissu
show
increas
express
mani
gene
associ
interferon
signal
earli
infect
immun
cytokin
respons
sustain
throughout
cours
infect
also
observ
number
gene
mani
involv
interferon
respons
differenti
express
similar
fashion
lung
blood
sampl
particularli
earli
infect
find
suggest
microarray
analys
blood
sampl
may
hold
promis
diagnost
applic
final
studi
also
includ
first
kind
global
proteom
analysi
macaqu
lung
tissu
analysi
identifi
protein
consist
gene
express
data
proteom
data
also
reveal
increas
abund
mani
protein
involv
innat
immun
respons
influenza
virologist
would
nt
interest
understand
molecular
mechan
underli
extrem
pathogenesi
viru
respons
influenza
pandem
studi
relat
viru
kill
estim
million
peopl
worldwid
remain
promin
fixtur
laboratori
genom
analys
provid
import
new
insight
made
viru
lethal
first
experi
associ
viru
evalu
global
gene
express
pattern
cell
infect
wildtyp
influenza
engin
virus
lack
part
gene
viru
contain
gene
pandem
viru
delet
gene
increas
magnitud
express
cellular
gene
implic
interferon
antivir
pathway
viru
ctermin
delet
gene
induc
cellular
gene
express
pattern
intermedi
pattern
induc
wildtyp
knockout
virus
contrast
viru
contain
gene
pandem
viru
effici
block
express
interferonregul
gene
parent
viru
togeth
result
suggest
cellular
respons
influenza
viru
significantli
influenc
gene
particularli
effect
interferon
antagonist
cours
sinc
learn
stori
much
complic
next
use
mous
infect
model
assess
contribut
ha
na
gene
viral
pathogenesi
studi
led
john
kash
evalu
mouseadapt
awsn
virus
engin
contain
ha
na
gene
viru
nonleth
anew
viru
microarray
analys
perform
lung
tissu
isol
infect
anim
show
activ
mani
gene
involv
inflammatori
respons
includ
cytokin
apoptosi
lymphocyt
gene
howev
consist
histopatholog
analysi
parent
hana
wsn
recombin
virus
show
increas
express
gene
associ
activ
cell
macrophag
well
gene
involv
apoptosi
tissu
injuri
oxid
damag
observ
mice
infect
new
caledonia
hana
wsn
viru
studi
document
clear
differ
gene
express
profil
correl
pulmonari
diseas
patholog
suggest
intrins
properti
ha
na
protein
may
product
longer
sever
immun
respons
culmin
destruct
viral
infect
reconstruct
eight
gene
segment
pandem
viru
provid
opportun
find
genom
could
reveal
highvirul
phenotyp
viru
initi
character
viru
terrenc
tumpey
colleagu
demonstr
highli
virul
mice
anim
die
within
five
day
infect
genom
analys
led
john
kash
show
anim
infect
reconstruct
viru
show
increas
acceler
activ
gene
associ
proinflammatori
celldeath
pathway
h
infect
significantli
gene
remain
activ
death
anim
contrast
less
dramat
delay
host
immun
respons
less
sever
diseas
patholog
mice
infect
influenza
virus
contain
subset
gene
viru
find
indic
cooper
interact
influenza
gene
suggest
enhanc
inflammatori
celldeath
respons
may
contribut
sever
immunopatholog
recent
work
reconstruct
viru
done
collabor
yoshihiro
kawaoka
studi
evalu
host
respons
reconstruct
viru
use
cynomolgu
macaqu
infect
model
viru
replic
high
level
spread
rapidli
throughout
respiratori
tract
infect
anim
caus
sever
damag
mass
infiltr
immun
cell
throughout
cours
infect
genom
analys
reveal
viru
trigger
aberrantli
high
sustain
express
numer
gene
involv
innat
immun
respons
includ
proinflammatori
cytokin
chemokin
earli
sustain
host
respons
macaqu
infect
viru
similar
observ
mice
indic
critic
host
respons
influenc
diseas
outcom
may
occur
earli
infect
interestingli
viru
also
appear
select
attenu
express
specif
innat
immun
respons
gene
includ
certain
gene
associ
type
interferon
respons
determin
mechan
attenu
possibl
viral
gene
may
play
role
regul
respons
although
detail
remain
uncov
atyp
innat
immun
respons
induc
viru
insuffici
protect
may
actual
contribut
lethal
viru
interest
combin
genom
macaqu
infect
model
led
establish
divis
function
genom
infecti
diseas
washington
nation
primat
research
center
laboratori
central
compon
divis
devot
develop
genom
proteom
technolog
along
richard
smith
group
pnnl
immunolog
resourc
collabor
edward
clark
muralikrishna
kaja
advanc
comput
bioinformat
applic
enhanc
use
nonhuman
primat
model
influenza
viru
infect
aid
goal
develop
appli
tool
need
perform
comprehens
integr
analys
nonhuman
primat
analyz
respons
viru
infect
multipl
point
along
flow
biolog
inform
whole
anim
dna
rna
protein
biolog
function
figur
integr
divers
type
data
opportun
better
understand
dynam
host
respons
infect
molecular
mechan
underli
progress
virusmedi
diseas
immunopatholog
develop
protect
immun
also
opportun
better
understand
gene
express
chang
respons
infect
translat
chang
protein
abund
function
chang
correl
clinic
outcom
moreov
opportun
assess
chang
gene
express
protein
abund
affect
immun
cell
function
innat
immun
respons
develop
link
adapt
immun
ultim
believ
integr
approach
translat
molecular
signatur
predict
protect
immun
patholog
biomark
diagnost
prognost
assay
ration
base
improv
antivir
therapi
vaccin
strategi
studi
outlin
review
provid
glimps
use
genom
proteom
technolog
unravel
complex
virushost
interact
addit
work
hcv
influenza
use
genom
approach
studi
varieti
virus
tracey
baa
head
collabor
research
sar
coraonaviru
herp
simplex
viru
work
pandem
influenza
john
kash
also
lead
effort
focus
ebola
viru
vaccinia
viru
matthew
thoma
michael
agi
explor
gene
express
chang
associ
simian
immunodefici
viru
infect
also
work
michael
gale
west
nile
viru
work
ipk
cellular
pkr
inhibitor
even
explor
gene
express
pattern
associ
pancreat
deplet
diabet
mice
jami
fornek
continu
work
ipk
includ
use
ipk
knockout
mice
genom
examin
role
pkr
inhibitor
influenza
viru
infect
gregori
zornetz
develop
target
proteom
approach
identifi
proteinprotein
interact
associ
key
viral
protein
technolog
use
continu
improv
data
accumul
ever
increas
rate
today
microarray
repres
gene
tenfold
start
togeth
assort
control
array
impress
oligonucleotid
per
slide
barri
robinson
work
incorpor
laser
captur
microdissect
studi
give
first
opportun
examin
gene
express
chang
occur
specif
cell
type
isol
complex
tissu
bioinformat
capabl
becom
evermor
sophist
jon
rue
eric
flamo
matthew
hard
ensur
stay
atop
recent
advanc
data
manag
analysi
express
array
manag
databas
contain
inform
express
profil
repres
million
measur
differenti
gene
express
discuss
elsewher
futur
virolog
depend
make
progress
understand
thing
work
system
level
must
ensur
genom
proteom
technolog
simpli
gener
ever
larger
quantiti
data
without
provid
clue
underli
function
nevertheless
confid
technolog
experiment
system
continu
progress
data
integr
strategi
becom
matur
function
genom
make
ever
greater
contribut
virolog
exampl
continu
take
use
genom
new
direct
robert
palermo
work
togeth
marjori
robertguroff
nation
cancer
institut
pursu
genom
approach
improv
aid
vaccin
develop
genom
analys
vaccin
trial
may
reveal
gene
express
marker
protect
immun
gene
express
chang
indic
predisposit
particular
respons
immun
subsequ
challeng
told
past
eight
year
excit
journey
full
discoveri
look
forward
new
breakthrough
futur
inde
life
milstein
award
nt
bad
represent
rang
virus
experiment
system
evalu
use
genom
proteom
technolog
highlight
experi
relat
use
mani
experiment
system
particularli
hepat
c
viru
influenza
summar
review
sarscov
sever
acut
respiratori
syndromeassoci
coronaviru
siv
simian
immunodefici
viru
wnv
west
nile
viru
human
immunodefici
viru
type
herp
simplex
viru
type
eam
express
array
manag
divis
function
genom
infecti
diseas
provid
viru
infect
model
clinic
genom
proteom
immunolog
resourc
need
perform
comprehens
analys
nonhuman
primat
allow
us
analyz
respons
viru
infect
multipl
point
along
flow
biolog
inform
est
express
sequenc
tag
amt
accur
mass
time
